Close Menu

Waters

The agency approved the Acquity UPLC I-Class IVD/Xevo TQ-S IVD LC-MS for clinical analysis of various targets.

Many of the meeting's proteomics presentations concerned not so much mass spec analysis itself as the refinement of processes and workflows leading up to it.

PerkinElmer's liquid and gas chromatography portfolio will be standardized on Waters' Empower Software.

The company's total revenues increased to $584 million from $565 million in the prior-year period, besting the consensus analyst estimate of $582 million.

From research collaborations to corporate acquisitions, attention from the broader scientific community highlighted the field's capabilities and limitations.

Mass spec instrumentation showed solid growth in Q3, with particular strength in academic and government markets.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the third quarter were up 8 percent year over year, driven by broad-based demand for its instrument systems.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has developed a new mass spec workflow that, according to company researchers, combines the advantages of data-independent and data-dependent analyses.

Waters has released its XBridge Protein BEH SEC Columns for size-based separations of protein-based biotherapeutics.

MADRID (GenomeWeb) – With the proteomics field closing in – at least by some measures – on its long-held goal of characterizing the complete human proteome, the question of how to confidently identify and validate the proteins still outstanding received much discussion this week at the Human Prot

Pages

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.